- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 30, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by HealthLeaders cited a study published in the September 2022 issue of The American Journal of Managed Care® (AJMC®). In the study, “Insurers Negotiate Lower Hospital Prices for HIX Than for Commercial Groups,” hospital price transparency data suggested that health insurance exchange plans get lower negotiated rates than commercial group plans and higher negotiated rates than Medicare Advantage plans.
Another piece by HealthLeaders spotlighted an article published on AJMC.com, the website of AJMC®. The article covered recent daily news updates, including how nonprofit hospitals pursue profits from low-income patients and an announcement by the Biden administration that $1.5 billion would be set aside to battle opioid overdoses and support recovery.
An article by Digital Health referenced a 2020 study published in a supplement to AJMC®, titled “Economic Burden of Alzheimer Disease and Managed Care Considerations.” The study indicated that health care costs associated with the treatment of Alzheimer disease were an estimated $305 billion in 2020.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
